Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2019-02-27 2019-02-19
Drug Identification Number 02417170 02417170
Brand name CONSTELLA CONSTELLA
Common or Proper name CONSTELLA 290MCG CAP 30 CA CONSTELLA 290MCG CAP 30 CA
Company Name ALLERGAN INC ALLERGAN INC
Ingredients Linaclotide Linaclotide
Strength(s) 290MCG 290MCG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 290MCG CAP 30 290MCG CAP 30
ATC code A06AX A06AX
ATC description DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-02-14 2019-02-14
Estimated end date 2019-03-01 2019-02-22
Actual end date 2019-02-26
Shortage status Resolved Actual shortage
Company comments 72 & 145 mcg are available. 72 & 145 mcg are available.
Health Canada comments